Role of new drug carbetocin for prevention of excessive bleeding after delivery.

“Role of carbetocin in prevention of postpartum hemorrhage ? - A Randomised Controlled Trial ?. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062341

Enrollment

Registered

2024-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O721- Other immediate postpartum hemorrhage

Interventions

Intervention1: To compare carbetocin with oxytocin Comparator agent is oxytocin: Group A (study group) will be given 100mcg carbetocin intramuscular injection single dose for one year Group B (referen

Eligibility

Inclusion criteria

Inclusion criteria: Patients age >18 and < 40 years undergoing vaginal delivery or caesarean section

Exclusion criteria

Exclusion criteria: 1. Coagulopathy 2. Drug hypersensitivity 3. Liver or kidney disease 4. Suspected placental pathology ( accreta,previa) 5. Placental abruption

Design outcomes

Primary

Measure	Time frame
Postpartum hemorrhage will be assessed after giving drugs for one hour post deliveryTimepoint: 1 hour post delivery	—

Secondary

Measure	Time frame
Check for vitals and bleeding P/vTimepoint: 24 hours	—

Countries

India

Contacts

Public ContactDr Shobha Mukherjee

Rohilkhand medical college and hospital

shosa1974@gmail.com9319854442

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026